We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$25.9B
AUM Growth
-$5.02B
(-16%)
Cap. Flow
-$1,000M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
43.79%
Holding
139
New
6
Increased
35
Reduced
74
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$150M |
| 2 |
BILL Holdings
BILL
|
+$145M |
| 3 |
Lowe's Companies
LOW
|
+$87.7M |
| 4 |
Uber
UBER
|
+$62.9M |
| 5 |
Baidu
BIDU
|
+$56.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$195M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$161M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$126M |
| 4 |
Atlassian
TEAM
|
+$121M |
| 5 |
Lam Research
LRCX
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.71% |
| 2 | Consumer Discretionary | 10.65% |
| 3 | Financials | 6.39% |
| 4 | Communication Services | 6.11% |
| 5 | Healthcare | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Qualcomm
QCOM
$173B
| $68.6M | 0.26% |
624,300
-502,500
| -45% | -$58.8M |
|
77
Keros Therapeutics
KROS
$213M
| $66.9M | 0.26% |
1,392,402
+183,580
| +15% | +$8.58M |
|
78
Rhythm Pharmaceuticals
RYTM
$7.95B
| $65.2M | 0.25% |
2,238,262
+533,262
| +31% | +$13.7M |
|
79
New Oriental
EDU
$9.11B
| $64.1M | 0.25% |
1,840,510
-2,097,950
| -53% | -$59.3M |
|
80
PTC
PTC
$16.5B
| $61.4M | 0.24% |
511,240
-154,642
| -23% | -$18.5M |
|
81
Lyft
LYFT
$6.52B
| $58.9M | 0.23% |
5,345,975
-2,477,455
| -32% | -$29.9M |
|
82
XP
XP
$8.4B
| $53.9M | 0.21% |
3,513,936
-540,192
| -13% | -$9.45M |
|
83
KKR & Co
KKR
$92.8B
| $50.9M | 0.2% |
1,096,213
-168,796
| -13% | -$8.23M |
|
84
Shopify
SHOP
$200B
| $49.3M | 0.19% |
1,418,914
-211,449
| -13% | -$7.22M |
|
85
Elastic
ESTC
$7.89B
| $47.4M | 0.18% |
920,800
+265,380
| +40% | +$15.9M |
|
|
GTM
86
ZoomInfo Technologies
GTM
$1.24B
| $45.5M | 0.18% |
1,510,007
-1,128,213
| -43% | -$38.9M |
|
|
XM
87
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $44.3M | 0.17% |
4,268,003
-1,522,160
| -26% | -$15.9M |
|
88
Sea Limited
SE
$70B
| $44.2M | 0.17% |
849,094
-123,914
| -13% | -$6.68M |
|
89
Peloton Interactive
PTON
$2.4B
| $38.4M | 0.15% |
4,834,121
-603,546
| -11% | -$5.79M |
|
90
Dynatrace
DT
$14.5B
| $37.4M | 0.14% |
976,678
-694,847
| -42% | -$25.3M |
|
91
TG Therapeutics
TGTX
$7.53B
| $36M | 0.14% |
3,044,417
+1,401,742
| +85% | +$10.2M |
|
92
Cintas
CTAS
$80.8B
| $35.5M | 0.14% |
314,412
-48,940
| -13% | -$5.29M |
|
93
CALL
RingCentral
RNG
$5.41B
| $35.3M | 0.14% |
998,500
-501,500
| -33% | -$17.9M |
|
|
CERE
94
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $33.6M | 0.13% |
1,064,401
-104,195
| -9% | -$2.94M |
|
95
Xometry
XMTR
$5.27B
| $33.6M | 0.13% |
1,041,079
+307,549
| +42% | +$14.4M |
|
|
DICE
96
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $32.4M | 0.13% |
+1,038,125
| New | +$33.9M |
|
97
TransUnion
TRU
$15.2B
| $29.5M | 0.11% |
520,519
-396,165
| -43% | -$23.2M |
|
98
GitLab
GTLB
$6.83B
| $29.5M | 0.11% |
649,206
| – | – |
|
|
CFLT
99
DELISTED
Confluent
CFLT
| $28.6M | 0.11% |
1,283,816
-128,308
| -9% | -$2.97M |
|
100
Certara
CERT
$1.22B
| $23.7M | 0.09% |
1,474,905
-377,645
| -20% | -$5.48M |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Alkeon Capital Management held 139 positions worth $25.9B, down 16% from $30.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Alkeon Capital Management withdrew a net $1,000M in Q4 2022, closing 12 positions and reducing 74 holdings. Its most notable exit was Alteryx Inc, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Alkeon Capital Management opened a new position in DICE Therapeutics, Inc. Common Stock worth $32.4M.
- Alkeon Capital Management's largest Q4 2022 buy was DICE Therapeutics, Inc. Common Stock: 1,038,125 shares worth $32.4M.
- Alkeon Capital Management added most to Meta Platforms (Facebook) in Q4 2022, an estimated $150M increase.
- Alkeon Capital Management's biggest Q4 2022 reduction was KLA, cutting an estimated $195M.
- Alkeon Capital Management fully exited Alteryx Inc in Q4 2022, selling an estimated $126M.
- Alkeon Capital Management's ten largest holdings make up 44% of its $25.9B portfolio in Q4 2022.
- Alkeon Capital Management opened 6 new positions and closed 12 in Q4 2022.
- Alkeon Capital Management's portfolio value fell 16% quarter-over-quarter to $25.9B.
Based on Alkeon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.